Traphaco JSC (HOSE:TRA)
79,000
0.00 (0.00%)
At close: May 22, 2026
Traphaco JSC Revenue
Traphaco JSC had revenue of 632.85B VND in the quarter ending March 31, 2026, with 14.05% growth. This brings the company's revenue in the last twelve months to 2.74T, up 16.16% year-over-year. In the year 2025, Traphaco JSC had annual revenue of 2.66T with 13.21% growth.
Revenue (ttm)
2.74T
Revenue Growth
+16.16%
P/S Ratio
1.20
Revenue / Employee
1.77B
Employees
1,546
Market Cap
3.27T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.66T | 309.99B | 13.21% |
| Dec 31, 2024 | 2.35T | 47.99B | 2.09% |
| Dec 31, 2023 | 2.30T | -99.68B | -4.16% |
| Dec 31, 2022 | 2.40T | 238.08B | 11.02% |
| Dec 31, 2021 | 2.16T | 251.97B | 13.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DHG Pharmaceutical JSC | 5.27T |
| Ha Tay Pharmaceutical JSC | 2.40T |
| Imexpharm | 2.39T |
| Domesco Medical Import - Export Joint-Stock | 2.12T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.87T |
| Cuu Long Pharmaceutical JSC | 1.31T |
| OPC Pharmaceutical JSC | 1.13T |
| Vidipha Central Pharmaceutical JSC | 971.25B |